CN106420884A - 一种含金银花提取物的药物组合物及口腔喷剂 - Google Patents
一种含金银花提取物的药物组合物及口腔喷剂 Download PDFInfo
- Publication number
- CN106420884A CN106420884A CN201611146316.7A CN201611146316A CN106420884A CN 106420884 A CN106420884 A CN 106420884A CN 201611146316 A CN201611146316 A CN 201611146316A CN 106420884 A CN106420884 A CN 106420884A
- Authority
- CN
- China
- Prior art keywords
- flos lonicerae
- lonicerae extract
- pharmaceutical composition
- composition containing
- containing flos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 36
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 14
- 241000205585 Aquilegia canadensis Species 0.000 title abstract 4
- 229940041678 oral spray Drugs 0.000 title abstract 2
- 239000000668 oral spray Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 9
- 230000036039 immunity Effects 0.000 claims abstract description 8
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241000222336 Ganoderma Species 0.000 claims abstract description 6
- 241000241413 Propolis Species 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 229940069949 propolis Drugs 0.000 claims abstract description 6
- 230000000391 smoking effect Effects 0.000 claims abstract description 4
- 241000628997 Flos Species 0.000 claims description 26
- 239000007921 spray Substances 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 12
- 230000006870 function Effects 0.000 claims description 9
- 206010013781 dry mouth Diseases 0.000 claims description 6
- 208000011580 syndromic disease Diseases 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 230000035807 sensation Effects 0.000 claims description 5
- 108010011485 Aspartame Proteins 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 4
- 229960003438 aspartame Drugs 0.000 claims description 4
- 235000010357 aspartame Nutrition 0.000 claims description 4
- 239000000605 aspartame Substances 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 4
- 238000001471 micro-filtration Methods 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 description 17
- 239000002904 solvent Substances 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000000242 pagocytic effect Effects 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Insects & Arthropods (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Husbandry (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种含金银花提取物的药物组合物及口腔喷剂,该组合物包括以下重量份的组分:金银花提取物0.05~0.2重量份,液体蜂胶0.01~0.05重量份,薄荷脑0.10~0.20重量份,灵芝孢子提取物0.10~0.20重量份。该含金银花提取物的药物组合物可显著改善抽烟后的口腔干涩、发苦的感觉,改善中医上火疱状,同时能够增强免疫力功能。
Description
技术领域
本发明属于制药技术领域,具体涉及一种含金银花提取物的药物组合物及口腔喷剂。
背景技术
口腔喷剂是近年来发展很快的药物及口用品制剂,具有方便快捷、见效快的特点,一般应用于肺部吸收药物或口腔保洁。但目前未见可以提高人体免疫力功能的同时改善抽烟后的口腔干涩、发苦的感觉和改善中医上火疱状的口腔喷剂。
发明内容
本发明的目的是克服上述不足之处,提供一种提高人体免疫力功能的同时改善抽烟后的口腔干涩、发苦的感觉和改善中医上火疱状的含金银花提取物的药物组合物。
本发明的另一目的是提供该组合物的口腔喷剂。
本发明还有一目的是提供该口腔喷剂的制备方法。
本发明的目的是通过以下方式实现的:
一种含金银花提取物的药物组合物,该组合物包括以下重量份的组分:
上述含金银花提取物的药物组合物优选包括以下重量份的组分:
上述组合物与药学可接受的辅料制成口服制剂,优选口服制剂为口喷剂。上述药物组合物可在制备改善抽烟后的口腔干涩、发苦的感觉或改善中医上火疱状的药物中应用。
上述含金银花提取物的药物组合物还可在制备增强免疫力功能的药物中应用。
上述含金银花提取物的口腔喷剂包括以下重量份的组分:
上述含金银花提取物的口腔喷剂优选包括以下重量份的组分:
上述含金银花提取物的口腔喷剂的制备方法包括以下步骤:
用纯净水将金银花提取物、灵芝孢子提取物、阿斯巴甜溶解,用浓度为95%的乙醇溶解液体蜂胶和薄荷脑,将水溶液和乙醇溶液两者混合均匀,微滤,灌装。
本发明使用的原料特性如下所示:
金银花提取物
液体蜂胶
灵芝孢子提取物
薄荷脑:按照《中华人民共和国药典》四部规定取用
通过药效试验说明本发明的有益效果:
(1)提高免疫力
取本发明实施例制备的含金银花提取物的口腔喷剂3.0ml/kg·bw/d、6.0ml/kg·bw/d、15.0ml/kg·bw/d三个剂量经口给予小鼠一个月,进行小鼠细胞免疫功能、体液免疫功能、单核-巨噬细胞功能及NK细胞活性测定。结果显示,细胞免疫功能试验的二硝基氟苯(DNFB)诱导的小鼠迟发性变态反应(DTH):受试物各剂量组小鼠耳廓肿胀度均高于溶剂对照组,方差分析及两两比较显示低剂量组小鼠耳廓肿胀度与溶剂对照组相比差异有统计学意义(P<0.01);ConA诱导的小鼠脾淋巴细胞转化实验(MTT法):受试物各剂量组光密度差值均高于溶剂对照组,方差分析及两两比较显示低剂量组和高剂量组与溶剂对照组值相比差异有统计学意义(P<0.01,P<0.05),该项结果阳性;单核-巨噬细胞功能试验中,小鼠碳廓清实验,受试物各剂量组吞噬指数a值均高于溶剂对照组,方差分析及两两比较显示,低、高剂量组吞噬指数a值与溶剂对照组差异有统计学意义(P<0.05,P<0.01);小鼠腹腔巨噬细胞吞噬鸡红细胞实验(滴片法):受试物各剂量组小鼠吞噬细胞吞噬百分率和吞噬指数均高于溶剂对照组,方差分析及两两比较显示,高剂量组吞噬吞噬率和吞噬指数与溶剂对照组差异均有统计学意义(P<0.01);NK细胞活性测定受试物各剂量组NK细胞活性高于溶剂对照组,方差分析及两两比较显示,低剂量组NK细胞活性与溶剂对照组差异有统计学意义(P<0.01)。综上,细胞免疫功能实验、单核-巨噬细胞功能实验和NK细胞活性测定结果均为阳性,根据《保健食品检验与评价技术规范》之增强免疫力功能试验的结果判定,本发明含金银花提取物的口腔喷剂具有增强免疫力功能。
(2)改善抽烟后的口腔干涩、发苦的感觉。
采用实施例1方法制备的口腔喷剂,经通过20例人体试食实验,每日喷用3次,每次喷2下,每次用量约0.5ml,喷用二天后,100%的试食者感觉有明显改善口腔干涩、发苦的症状。
(3)改善中医上火症状。
采用实施例1方法制备的口腔喷剂,经通过30例人体试食实验,每日喷用3次,每次喷2下,每次用量约0.5ml,喷用三天后,100%的试食者感觉有明显改善口角糜烂,口腔溃疡的症状。金银花味甘、性寒,能清热解毒、疏散风热,现代药理研究表明其提取物具有抗炎作用。
具体实施方式
以下通过具体实施例对本发明进行进一步说明:
实施例1
配方:
制备方法:
用纯净水将金银花提取物、灵芝孢子提取物、阿斯巴甜溶解,用质量浓度为95%的乙醇溶解液体蜂胶和薄荷脑,将水溶液和乙醇溶液两者混合均匀,微滤,灌装。
实施例2
配方:
制备方法:
用纯净水将金银花提取物、灵芝孢子提取物、阿斯巴甜溶解,用质量浓度为95%的乙醇溶解液体蜂胶和薄荷脑,将水溶液和乙醇溶液两者混合均匀,微滤,灌装。
Claims (9)
1.一种含金银花提取物的药物组合物,其特征在于该组合物包括以下重量份的组分:
2.根据权利要求1所述的含金银花提取物的药物组合物,其特征在于该组合物包括以下重量份的组分:
3.根据权利要求1或2所述的含金银花提取物的药物组合物,其特征在于该组合物与药学可接受的辅料制成口服制剂。
4.根据权利要求3所述的含金银花提取物的药物组合物,其特征在于所述的口服制剂为口腔喷剂。
5.权利要求1所述的含金银花提取物的药物组合物在制备改善抽烟后的口腔干涩、发苦的感觉和改善中医上火疱状的药物中的应用。
6.权利要求1或2所述的含金银花提取物的药物组合物在制备增强免疫力功能的药物中的应用。
7.一种含金银花提取物的口腔喷剂,其特征在于该口腔喷剂包括以下重量份的组分:
8.根据权利要求7所述的含金银花提取物的口腔喷剂,其特征在于该口腔喷剂包括以下重量份的组分:
9.一种权利要求7或8所述的含金银花提取物的口腔喷剂的制备方法,其特征在于该方法包括以下步骤:
用纯净水将金银花提取物、灵芝孢子提取物、阿斯巴甜溶解,用浓度为95%的乙醇溶解液体蜂胶和薄荷脑,将水溶液和乙醇溶液两者混合均匀,微滤,灌装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611146316.7A CN106420884A (zh) | 2016-12-13 | 2016-12-13 | 一种含金银花提取物的药物组合物及口腔喷剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611146316.7A CN106420884A (zh) | 2016-12-13 | 2016-12-13 | 一种含金银花提取物的药物组合物及口腔喷剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106420884A true CN106420884A (zh) | 2017-02-22 |
Family
ID=58216435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611146316.7A Pending CN106420884A (zh) | 2016-12-13 | 2016-12-13 | 一种含金银花提取物的药物组合物及口腔喷剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106420884A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112022791A (zh) * | 2020-09-24 | 2020-12-04 | 三泉(泉州)生物科技有限公司 | 一种草本抑菌漱口水及其制备方法 |
CN112293740A (zh) * | 2020-10-29 | 2021-02-02 | 中慈保健品科技开发有限公司 | 一种增强免疫力的组合物及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101810336A (zh) * | 2010-04-30 | 2010-08-25 | 广东仙乐制药有限公司 | 一种咀嚼性软胶囊及其制备方法 |
CN103610726A (zh) * | 2013-11-21 | 2014-03-05 | 江苏江大源生态生物科技有限公司 | 一种复方蜂胶口腔消毒喷剂及其制备方法 |
-
2016
- 2016-12-13 CN CN201611146316.7A patent/CN106420884A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101810336A (zh) * | 2010-04-30 | 2010-08-25 | 广东仙乐制药有限公司 | 一种咀嚼性软胶囊及其制备方法 |
CN103610726A (zh) * | 2013-11-21 | 2014-03-05 | 江苏江大源生态生物科技有限公司 | 一种复方蜂胶口腔消毒喷剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
常亮等: "蜂胶口腔保健喷剂的工艺", 《食品研究与开发》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112022791A (zh) * | 2020-09-24 | 2020-12-04 | 三泉(泉州)生物科技有限公司 | 一种草本抑菌漱口水及其制备方法 |
CN112293740A (zh) * | 2020-10-29 | 2021-02-02 | 中慈保健品科技开发有限公司 | 一种增强免疫力的组合物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101919802A (zh) | 口腔吸收固体解酒泡腾制剂 | |
CN104043068A (zh) | 破解癌症的致病因素和中医治疗方法 | |
CN105148017B (zh) | 一种具有润肺止咳功能的饮料 | |
CN106359720A (zh) | 一种清咽利喉和润肺清火的保健茶及其制备方法 | |
CN105360489A (zh) | 一种具有清咽利喉功效的凉茶及其制备方法 | |
CN106420884A (zh) | 一种含金银花提取物的药物组合物及口腔喷剂 | |
CN106538779A (zh) | 一种冷浸法制金莲花茶及其制备方法 | |
CN105477487A (zh) | 一种治疗慢性咽炎的药物及其制备方法 | |
CN104225196B (zh) | 一种治疗呼吸道疾病的中药泡腾片及其制备方法 | |
CN101284041B (zh) | 一种具有抗疲劳、抗缺氧作用的复方黄芪中药制剂 | |
CN105519731A (zh) | 一种陈皮茶泡腾片及其制备方法 | |
CN104383232B (zh) | 清热解毒苦丁茶含片及其生产方法 | |
JP2005023008A (ja) | ビタミンb群を含有する内服液剤組成物 | |
CN102631492B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN107349359B (zh) | 一种能够解酒的中药组合物 | |
CN103623203B (zh) | 一种咳舒口服制剂的制备方法 | |
CN1491589A (zh) | 一种防病保健饮料及其制法 | |
CN104622967A (zh) | 一种含无花果的药物组合物及其制备方法和用途 | |
CN103405723B (zh) | 一种用于小儿反复呼吸道感染的药物组合物 | |
CN104224819A (zh) | 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂 | |
CN102631486B (zh) | 一种保健组合物 | |
CN102885367A (zh) | 一种具有护嗓作用的胖大海饮料及其制备方法 | |
CN101244170B (zh) | 用于治疗小儿外感咳嗽的药物及制备方法 | |
CN103893158A (zh) | 木糖醇在雾霾性呼吸系统疾病中的应用 | |
CN102688333A (zh) | 治疗咳嗽的瓜蒌仁中药汤剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170222 |
|
RJ01 | Rejection of invention patent application after publication |